Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ansofaxine extended-release tablets for major depressive disorder
CTR20182047Phase 3Completed
- Sponsor
- Luye Pharma Group
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of toludesvenlafaxine in major depressive disorder (MDD), sponsored by Luye Pharma Group. Started Nov 2018; status: completed.
02
Drugs
toludesvenlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on CTR20182047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20182047.